Clinical Significance and Outcome of COVID-19 Patients with Thrombocytopenia in Intensive Care Unit: A Single Centre Study
Asian Hematology Research Journal,
Page 8-15
Abstract
Introduction: SARS-CoV-2 infection can cause manifestations in multiple systems in the body. Haematological system can also be affected by both SARS-CoV-2 infection and critical illness. There have been studies that show thrombocytopaenia is connected with SARS-CoV-2 infection. The data on its prevalence and outcome on critically ill COVID-19 patients are scarce. Some studies have shown that thrombocytopaenia is associated with worsening of respiratory parameters and unfavourable outcome of the critically ill patients. Identifying the presence of thrombocytopaenia and its consequences is important to manage critically ill COVID-19 patients.
Aims: To identify the prevalence and consequences of thrombocytopaenia, the presence of other causes of thrombocytopaenia and association of thrombocytopenia with the outcome in critically ill COVID-19 patients.
Study Design: A retrospective clinical analysis.
Study Set Up: This was done in COVID designated Intensive care unit and High dependency unit in Base Hospital- Teldeniya, Sri Lanka.
Methodology: A retrospective study was done at COVID designated intensive care unit- Base Hospital, Teldeniya, Sri Lanka. All patients with positive SARS-CoV-2 testing who later develops pneumonia with oxygen dependency and requiring ICU or HDU care were included in the study. Data was collected from patient records for the duration from 1st of January 2021 to 30th of June 2021. Their demographic data, data related to platelet counts, complications, outcome and other causes leading to thrombocytopaenia were collected. Thrombocytopaenia was categorised as mild (platelet count 100-150×109/L), Moderate (50-100×109/L) and severe (less than 50×109/L).
Results: Total of 189 patients were admitted to either ICU or HDU requiring oxygen therapy due to COVID pneumonia during the study period. The mean age was 60.59 years with SD of 14.9. Age range was 16 to 94 years. 63 patients (33.33%) had thrombocytopenia with 8 (12.69%), 19 (30.15%) and 36 (57.14%) had severe, moderate and mild thrombocytopenia respectively. 28 (44.4%) of the patients had low platelets at the time of admission. 31.7% of the patients had another cause that could contribute for thrombocytopenia. In thombocytapanic patients, there were significantly elevated levels of C-reactive protein and serum creatinine. Twenty (31.7%) of the patients with thrombocytopenia died. This accounted for 48.7% of all critical care deaths. When compared to patients with a normal platelet count, the proportion of deaths in patients with thrombocytopenia was found to be significant. (p=0.045).
Conclusions: In critically ill patients, thrombocytopenia can occur due to a variety of causes. According to our findings, at least one-third of critically ill patients with COVID-19 infection develop thrombocytopenia at some point during their illness. This group has a high mortality rate. It is critical to understand the progression of the illness as well as the outcome in order to plan discharge and follow-up for these patients.
Keywords:
- Thrombocytopenia
- COVID-19
- critically ill patients
- platelets
How to Cite
References
Available: https://covid19.who.int/table
Heo J, Han D, Kim HJ et al. Prediction of patients requiring intensive care for COVID-19: Development and validation of an integer-based score using data from centers for disease control and prevention of South Korea. J Intensive Care. 2021;9:16. Available:https://doi.org/10.1186/s40560-021-00527-x
Roberts CM, Levi M, McKee M, Schilling R, Lim WS, Grocott MPW. COVID-19: A complex multisystem disorder. Br J Anaesth. 2020;125(3):238-242.
DOI:10.1016/j.bja.2020.06.013
Vanderschueren S, De Weerdt A, Malbrain M et al. Thrombocytopenia and prognosis in intensive care. Crit Care Med. 2000;28(6):1871-1876.
Cawley MJ, Wittbrodt ET, Boyce EG et al. Potential risk factors associated with thrombocytopenia in a surgical intensive care unit. Pharmacotherapy. 1999;19(1): 108-113.
Stephan F, Hollande J, Richard O et al. Thrombocytopenia in a surgical ICU. Chest. 1999;115:1363-1370.
Chakraverty R, Davidson S, Peggs K et al. The incidence and cause of coagulopathies in an intensive care population. Br J Haematol. 1996;93(2): 460-463.
Crowther MA, Cook DJ, Meade MO et al. Thrombocytopenia in medical-surgical critically ill patients: Prevalence, incidence, and risk factors. J Crit Care. 2005;20(4): 348-353.
Moreau D, Timsit JF, Vesin A et al. Platelet count decline: An early prognostic marker in critically ill patients with prolonged ICU stays. Chest. 2007;131: 1735-1741.
Greenberg EM, Kaled ES. Thrombocytopenia. Crit Care Nurs Clin North Am. 2013;25(4):427-434.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020;395: 507-13.
Pranata R, Lim MA, Yonas E, Huang I, Nasution SA, Setiati S, Alwi I, Kuswardhani RAT. Thrombocytopenia as a prognostic marker in COVID-19 patients: Diagnostic test accuracy meta-analysis. Epidemiol Infect. 2021;149:e40.
DOI: 10.1017/S0950268821000236
PMID: 33509306; PMCID: PMC7889844
Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M, Psaltopoulou T, Gerotziafas G, Dimopoulos MA. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95(7): 834-847.
DOI: 10.1002/ajh.25829
Epub 2020 May 23. PMID: 32282949; PMCID: PMC7262337
Lippi, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta. 2020;506:145-148.
Qu R, Ling Y, Zhang YH, Wei LY, Chen X, XM Li et al. Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. J Med Virol. 2020;92(9):1533-1541.
Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol. 2020;99(6): 1205-1208.
DOI: 10.1007/s00277-020-04019-0
Epub 2020 Apr 15. PMID: 32296910; PMCID: PMC7156897
Mafalda Urbano, Elísio Costa, Catarina Geraldes, Hematological changes in SARS-COV-2 positive patients. Hematology, Transfusion and Cell Therapy. 2022;44(2):218-224.
Available:https://doi.org/10.1016/j.htct.2021.12.001
Zhang MK, Xu TQ, Zhang XJ, Rao ZG, He XX, Wu MQ, Li ZP, Liu Y, Yang JC, Gong YF, Tang M, Xue XY. Thrombocytopenia in 737 adult intensive care unit patients: A real-world study of associated factors, drugs, platelet transfusion, and clinical outcome. SAGE Open Med. 2020;7(8): 2050312120958908.
DOI: 10.1177/2050312120958908
PMID: 33110602; PMCID: PMC7564627
Ahmed I, Majeed A, Powell R. Heparin induced thrombocytopenia: Diagnosis and management update. Postgrad Med J. 2007;83(983):575-82.
DOI: 10.1136/pgmj.2007.059188
PMID: 17823223; PMCID: PMC2600013
Mohsen M. El-Khaiat, Ayman M. El-lehlah, Manal A. Kesheita, Mohamed Abdel-Samiee, Ahmed Abozaid Ahmed Teima, Association between thrombocytopenia and the severity of Covid-19 infection among hospitalized Egyptian patients, Annals of Medicine and Surgery. 2022;79: 103973.
ISSN: 2049-0801.
-
Abstract View: 16 times
PDF Download: 14 times
